OTC Pharmaceuticals - Zimbabwe

  • Zimbabwe
  • Revenue in the OTC Pharmaceuticals market amounts to US$114.40m in 2024. The market is expected to grow annually by -1.50% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$25.73m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$6.72 are generated in 2024.
  • In the OTC Pharmaceuticals market, 0.4% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Zimbabwe is experiencing significant growth and development.

Customer preferences:
Customers in Zimbabwe are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This is driven by a number of factors, including increasing awareness and knowledge about self-medication, convenience, and affordability. Consumers are becoming more proactive in managing their own health and are seeking accessible and cost-effective solutions for common ailments. As a result, there is a growing demand for OTC pharmaceuticals in Zimbabwe.

Trends in the market:
One of the key trends in the OTC Pharmaceuticals market in Zimbabwe is the expansion of product offerings. Pharmaceutical companies are introducing a wide range of OTC products to cater to the diverse needs of consumers. This includes medications for pain relief, cough and cold, allergies, and gastrointestinal issues, among others. The availability of a variety of OTC options allows consumers to choose the most suitable product for their specific health concerns. Another trend in the market is the increasing popularity of natural and herbal remedies. Zimbabwe has a rich tradition of using traditional herbal medicines for healing purposes, and this trend is now being reflected in the OTC Pharmaceuticals market. Consumers are seeking natural alternatives to conventional medications, driven by a growing interest in holistic health and wellness. As a result, pharmaceutical companies are incorporating natural and herbal ingredients into their OTC products to meet this demand.

Local special circumstances:
Zimbabwe has a unique healthcare landscape that influences the OTC Pharmaceuticals market. The country has a high burden of communicable diseases, such as HIV/AIDS and malaria, as well as non-communicable diseases, such as diabetes and hypertension. This creates a significant demand for OTC pharmaceuticals to manage these conditions. Additionally, the limited availability and affordability of prescription medications in Zimbabwe further drives the demand for OTC alternatives.

Underlying macroeconomic factors:
The development of the OTC Pharmaceuticals market in Zimbabwe is also influenced by underlying macroeconomic factors. The country has experienced economic challenges in recent years, including high inflation and currency instability. This has led to a decline in disposable income and reduced access to healthcare services. As a result, consumers are increasingly relying on OTC pharmaceuticals as a more affordable option for their healthcare needs. The affordability and accessibility of OTC products make them a viable alternative to prescription medications, especially for those who are unable to afford or access prescription drugs. In conclusion, the OTC Pharmaceuticals market in Zimbabwe is growing and evolving due to changing customer preferences, including the demand for a wide range of products and natural remedies. The local special circumstances, such as the high burden of diseases and limited access to prescription medications, further contribute to the development of the market. Additionally, underlying macroeconomic factors, such as economic challenges and reduced access to healthcare services, drive the demand for OTC pharmaceuticals as a more affordable option.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)